In contrast to the previously characterized type I systems known for uncontrolled cleavage and preferential targeting of dsDNA, this type I-F variant has been demonstrated to precisely cleave both ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Kano Therapeutics, a biotechnology company pioneering single-stranded DNA (ssDNA) as a safe, efficient and flexible biomolecule for gene insertions, today ...